National and regional activities by sickness funds in Austria to encourage the rational use of medicines Journal title: Generics and Biosimilars Initiative Journal Authors: Brian Godman Subject(s):
Access to liposomal generic formulations: beyond AmBisome and Doxil/Caelyx Journal title: Generics and Biosimilars Initiative Journal Authors: Sara Gaspani, Barbara Milani Subject(s):
Challenges to generic medicines utilization in Yemeni healthcare system Journal title: Generics and Biosimilars Initiative Journal Authors: Saleh Karamah AL-Tamimi, Mohamed Azmi Ahmad Hassali, Alian A Alrasheedy Subject(s):
How do regional sickness funds encourage more rational use of medicines, including the increase of generic uptake? A case study from Austria Journal title: Generics and Biosimilars Initiative Journal Authors: Sabine Vogler, Nina Zimmermann Subject(s):
Why bioequivalence and unconditional interchangeability of generic drugs are not the same Journal title: Generics and Biosimilars Initiative Journal Authors: Teun van Gelder Subject(s):
Equivalence of generic medicines in general and immunosuppressants in particular – a regulatory opinion on switching of ciclosporin, tacrolimus and mycophenolate mofetil Journal title: Generics and Biosimilars Initiative Journal Authors: Yang Yu, Hubert GM Leufkens, Marc Maliepaard Subject(s):
The generic pharmaceutical industry: moving beyond incremental innovation towards re-innovation Journal title: Generics and Biosimilars Initiative Journal Authors: Fereshteh Barei, Claude Le Pen, Steven Simoens Subject(s):
What lessons can be learned from the launch of generic clopidogrel? Journal title: Generics and Biosimilars Initiative Journal Authors: Christoph Baumgärtel, Brian Godman, Rickard E Malmstrom, Morten Andersen, Mohammed Abuelkhair, Shaja... Subject(s):
Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach Journal title: Generics and Biosimilars Initiative Journal Authors: Brian Godman, Mohammed Abuelkhair, Agnes Vitry, Shajahan Abdu, Marion Bennie, Iain Bishop, Sahar Fah... Subject(s):
Generic clopidogrel–the medicines agency’s perspective Journal title: Generics and Biosimilars Initiative Journal Authors: Christoph Baumgärtel Subject(s):
The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview Journal title: Generics and Biosimilars Initiative Journal Authors: Sabine Vogler Subject(s):
Generics substitution in primary care: summary of the Dutch community pharmacies guidelines Journal title: Generics and Biosimilars Initiative Journal Authors: Leonora Grandia, Arnold G Vulto Subject(s):
A review of generic medicine pricing in Europe Journal title: Generics and Biosimilars Initiative Journal Authors: Steven Simoens Subject(s):
European payer initiatives to reduce prescribing costs through use of generics Journal title: Generics and Biosimilars Initiative Journal Authors: Brian Godman Subject(s):
A review of patient perspectives on generics substitution: what are the challenges for optimal drug use Journal title: Generics and Biosimilars Initiative Journal Authors: Helle Håkonsen, Else-Lydia Toverud Subject(s):
